Renovaro Biosciences
RENB
#8953
Rank
C$0.11 B
Marketcap
$0.73
Share price
3.63%
Change (1 day)
-82.46%
Change (1 year)

EPS for Renovaro Biosciences (RENB)

EPS in 2023 (TTM): -$2.62

According to Renovaro Biosciences's latest financial reports the company's current EPS (TTM) is -$2.82. In 2022 the company made an earnings per share (EPS) of -$2.88 a decrease over its 2021 EPS that were of -$1.10.

EPS history for Renovaro Biosciences from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.62-8.86%
2022-$2.88160.76%
2021-$1.10243.48%
2020-$0.3243.75%
2019-$0.22-74.87%
2018-$0.89339.47%
2017-$0.20-48.26%
2016-$0.39-22.22%
2015-$0.507.39%
2014-$0.474351.27%
2013-$0.0105316.6%
2012-$0.009028